Activation of the miR-17 family and miR-21 during murine kidney ischemia-reperfusion injury

Nucleic Acid Therapeutics

Volumn 23, Issue 5, 2013, Pages 344-354

  Kaucsár, Tamás ^a   Révész, Csaba ^a   Godó, Mária ^a   Krenács, Tibor ^a   Albert, Mihály ^b   Szalay, Csaba Imre ^a   Rosivall, László ^a   Benyó, Zoltán ^a   Bátkai, Sándor ^c   Thum, Thomas ^c   Szénási, Gábor ^a   Hamar, Péter ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b Ceva Phylaxia Veterinary Biologicals Co Ltd   (Hungary)

^c HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MICRORNA; MICRORNA 106A; MICRORNA 10A; MICRORNA 10B; MICRORNA 16; MICRORNA 17; MICRORNA 181B; MICRORNA 185; MICRORNA 195; MICRORNA 20A; MICRORNA 21; MICRORNA 221; MICRORNA 30D; MICRORNA 9; MICRORNA 93; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; UNCLASSIFIED DRUG; UREA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HISTOLOGY; IMMUNOHISTOCHEMISTRY; KIDNEY; KIDNEY FUNCTION; KIDNEY ISCHEMIA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REPERFUSION INJURY; TISSUE MICROARRAY; UREA BLOOD LEVEL; UREA NITROGEN BLOOD LEVEL;

ACUTE KIDNEY INJURY; ACUTE-PHASE PROTEINS; ANIMALS; BLOOD UREA NITROGEN; GENE EXPRESSION REGULATION; KIDNEY; LIPOCALINS; MALE; MICE; MICE, INBRED C57BL; MICRORNAS; ONCOGENE PROTEINS; REPERFUSION INJURY; RNA, MESSENGER;

EID: 84883334997     PISSN: 21593337     EISSN: None     Source Type: Journal    
DOI: 10.1089/nat.2013.0438     Document Type: Article

References (65)

1. ARAGNO, M. CUTRIN, J.C., MASTROCOLA, R., PERRELLI, M.G., RESTIVO, F., POLI, G., DANNI, O., and BOCCUZZI, G. (2003). Oxidative stress and kidney dysfunction due to ischemia/ reperfusion in rat: Attenuation by dehydroepiandrosterone. Kidney Int. 64, 836-843.
2. ARMITAGE, P. (1980). Statistical Methods in Medical Research. (Blackwell Scientific Publications, Oxford, UK), pp. 279-301.
3. BASILE, D.P. (2007). The endothelial cell in ischemic acute kidney injury: Implications for acute and chronic function. Kidney Int. 72, 151-156.
4. BROCK, M., TRENKMANN, M., GAY, R.E., MICHEL, B.A., GAY, S., FISCHLER, M., ULRICH, S., SPEICH, R., and HUBER, L.C. (2009). Interleukin-6 modulates the expression of the bone morphogenic protein receptor type II through a novel STAT3-microRNA cluster 17/92 pathway. Circ. Res. 104, 1184-1191.
5. BURNE, M.J., HAQ, M., MATSUSE, H., MOHAPATRA, S., and RABB, H. (2000). Genetic susceptibility to renal ischemia reperfusion injury revealed in a murine model. Transplantation 69, 1023-1025.
6. CHEN, C., TAN, R., WONG, L., FEKETE, R., and HALSEY, J. (2011). Quantitation of microRNAs by real-time RT-qPCR. Methods Mol. Biol. 687, 113-134.
7. CHENG, Y., ZHU, P., YANG, J., LIU, X., DONG, S., WANG, X., CHUN, B., ZHUANG, J., and ZHANG, C. (2010). Ischaemic preconditioning-regulated miR-21 protects heart against ischaemia/ reperfusion injury via anti-apoptosis through its target PDCD4. Cardiovasc. Res. 87, 431-439.
8. CHOMCZYNSKI, P. (1993). A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Biotechniques 15, 532-534, 536-537.
9. CONNOLLY, E., MELEGARI, M., LANDGRAF, P., TCHAIKOVSKAYA, T., TENNANT, B. C, SLAGLE, B.L., ROGLER, L.E., M. ZAVOLAN, TUSCHL, T., and ROGLER, C.E. (2008). Elevated expression of the miR-17-92 polycistron and miR-21 in hepadnavirus-associated hepatocellular carcinoma contributes to the malignant phenotype. Am. J. Pathol. 173, 856-864.
10. DEVARAJAN, P. (2006). Update on mechanisms of ischemic acute kidney injury. J. Am. Soc. Nephrol. 17, 1503-1520.
11. DEVARAJAN, P., MISHRA, J., SUPAVEKIN, S., PATTERSON, L.T., and STEVEN POTTER, S. (2003). Gene expression in early ischemic renal injury: Clues towards pathogenesis, biomarker discovery, and novel therapeutics. Mol. Genet. Metab. 80, 365-376.
12. DEWS, M., HOMAYOUNI, A., YU, D., MURPHY, D., SEVIGNANI, C., WENTZEL, E., FURTH, E.E., LEE, W.M., ENDERS, G. H, MENDELL, J.T., and THOMAS-TIKHONENKO, A. (2006). Augmentation of tumor angiogenesis by a Mycactivated microRNA cluster. Nat. Genet. 38, 1060-1065.
13. DU, J., CAO, X., L. ZOU, CHEN, Y., GUO, J., Z. CHEN, HU, S., and ZHENG, Z. (2013). MicroRNA-21 and Risk of Severe Acute Kidney Injury and Poor Outcomes after Adult Cardiac Surgery. PLoS One 8, e63390.
14. EEFTING, F., RENSING, B., WIGMAN, J., PANNEKOEK, W.J., LIU, W.M., CRAMER, M.J., LIPS, D.J., and DOEVENDANS, P.A. (2004). Role of apoptosis in reperfusion injury. Cardiovasc. Res. 61, 414-426.
15. EULALIO, A., HUNTZINGER, E., and IZAURRALDE, E. (2008). Getting to the root of miRNA-mediated gene silencing. Cell 132, 9-14.
16. FERNANDO, T.R., RODRIGUEZ-MALAVE, N.I., and RAO, D.S. (2012). MicroRNAs in B cell development and malignancy. J. Hematol. Oncol. 5, 7.
17. FONTANA, L., PELOSI, E., GRECO, P., RACANICCHI, S., TESTA, U., LIUZZI.F., CROCE, C.M., E. BRUNETTI, GRIGNANI, F., and PESCHLE, C. (2007). MicroRNAs 17-5p- 20a-106a control monocytopoiesis through AML1 targeting and M-CSF receptor upregulation. Nat. Cell Biol. 9, 775-787.
18. GODWIN, J.G., GE, X., STEPHAN, K., JURISCH, A., TULLIUS, S.G., and IACOMINI, J. (2010). Identification of a microRNA signature of renal ischemia reperfusion injury. Proc. Natl. Acad. Sci. U. S. A. 107, 14339-14344.
19. GOLDBERG, R., and DENNEN, P. (2008). Long-term outcomes of acute kidney injury. Adv. Chronic Kidney Dis. 15, 297-307.
20. GRAMS, M.E., ESTRELLA, M.M., CORESH, J., BROWER, R.G., and LIU, K.D. (2011). Fluid balance, diuretic use, and mortality in acute kidney injury. Clin. J. Am. Soc. Nephrol. 6, 966-973.
21. KIDNEY DISEASE: IMPROVING GLOBAL OUTCOMES (KDIGO) ACUTE KIDNEY INJURY WORK GROUP. (2012). KDIGO Clinical Practice guideline for acute kidney injury. Kidney Int. 2,1-138.
22. HAMAR, P., SONG, E., G. KOKENY, CHEN, A., OUYANG, N., and LIEBERMAN, J. (2004). Small interfering RNA targeting Fas protects mice against renal ischemia-reperfusion injury. Proc. Natl. Acad. Sci. U. S. A. 101, 14883-14888.
23. HEEMANN, U., SZABO, A., HAMAR, P., MULLER, V., WITZKE, O., LUTZ, J., and PHILIPP, T. (2000). Lipopolysaccharide pretreatment protects from renal ischemia/ reperfusion injury: Possible connection to an interleukin-6-dependent pathway. Am. J. Pathol. 156, 287-293.
24. JIA, P., TENG, J., J. ZOU, FANG, Y., ZHANG, X., BOSNJAK, Z.J., LIANG, M., and DING, X. (2013). miR-21 Contributes to Xenon-conferred Amelioration of Renal Ischemia-Reperfusion Injury in Mice. Anesthesiology [Epub ahead of print]; DOI:10.1097/ALN.0b013e318298e5f1.
25. JIANG, S., TANG, Q., RONG, R., L. TANG, XU, M., LU, J., JIA, Y., OOI, Y., HOU, J., GUO, J., YANG, B., and ZHU, T. (2012). Mycophenolate mofetil inhibits macrophage infiltration and kidney fibrosis in long-term ischemia-reperfusion injury. Eur. J. Pharmacol. 688, 56-61.
26. KAUCSAR, T., RACZ, Z., and HAMAR, P. (2010). Post-transcriptional gene-expression regulation by micro RNA (miRNA) network in renal disease. Adv. Drug. Deliv. Rev. 62, 1390-1401.
27. KINSEY, G.R., LI, L., and OKUSA, M.D. (2008). Inflammation in acute kidney injury. Nephron Exp. Nephrol. 109, e102-107.
28. KOGA, Y., YASUNAGA, M., TAKAHASHI, A., KURODA, J., MORIYA, Y., AKASU, T., FUJITA, S., YAMAMOTO, S., BABA, H., and MATSUMURA, Y. (2010). MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening. Cancer Prev. Res. (Phila) 3, 1435-1442.
29. KOSIERADZKI, M., and ROWINSKI, W. (2008). Ischemia/reperfusion injury in kidney transplantation: Mechanisms and prevention. Transplant Proc. 40(10), 3279-3288.
30. KRENACS, T., FICSOR, L., VARGA, S.V., ANGELI, V., and MOLNAR, B. (2010). Digital microscopy for boosting database integration and analysis in TMA studies. Methods Mol. Biol. 664, 163-175.
31. KUTAY, H., BAI, S., DATTA, J., MOTIWALA, T., POGRIBNY, I., FRANKEL, W., JACOB, S.T., and GHOSHAL, K. (2006). Downregulation of miR-122 in the rodent and human hepatocellular carcinomas. J. Cell. Biochem. 99, 671-678.
32. LAGOS-QUINTANA, M., RAUHUT, R., LENDECKEL, W., and TUSCHL, T. (2001). Identification of novel genes coding for small expressed RNAs. Science 294, 853-858.
33. LAMEIRE, N., VAN BIESEN, W., and VANHOLDER, R. (2006). The changing epidemiology of acute renal failure. Nat. Clin. Pract. Nephrol. 2, 364-377.
34. LEUNG, K.C., TONELLI, M., and JAMES, M.T. (2013). Chronic kidney disease following acute kidney injury-risk and outcomes. Nat. Rev. Nephrol. 9, 77-85.
35. LIEBERTHAL, W., and NIGAM, S.K. (1998). Acute renal failure. I. Relative importance of proximal vs. distal tubular injury. Am. J. Physiol. 275, F623-631.
36. LINKERMANN, A., BRASEN, J.H., HIMMERKUS, N., LIU, S., HUBER, T.B., KUNZENDORF, U., and KRAUTWALD, S. (2012). Rip1 (receptor-interacting protein kinase 1) mediates necroptosis and contributes to renal ischemia/reperfusion injury. Kidney Int. 81, 751-761.
37. LIU, X.S., CHOPP, M., ZHANG, R.L., TAO, T., WANG, X.L., KASSIS, H., HOZESKA-SOLGOT, A., L. ZHANG, CHEN, C., and ZHANG, Z.G. (2011). MicroRNA profiling in subventricular zone after stroke: MiR-124a regulates proliferation of neural progenitor cells through Notch signaling pathway. PLoS One 6, e23461.
38. MATSUBARA, H., TAKEUCHI, T., NISHIKAWA, E., YANAGISAWA, K., HAYASHITA, Y., EBI, H., YAMADA, H., SUZUKI, M., NAGINO, M., NIMURA, Y., OSADA, H., and TAKAHASHI, T. (2007). Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92. Oncogene 26, 6099-6105.
39. MISHRA, J., MA, Q., PRADA, A., MITSNEFES, M., ZAHEDI, K., YANG, J., BARASCH, J., and DEVARAJAN, P. (2003). Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J. Am. Soc. Nephrol. 14, 2534-2543.
40. MOLITORIS, B.A. (2003). Transitioning to therapy in ischemic acute renal failure. J. Am. Soc. Nephrol. 14, 265-267.
41. NIE, Y., HAN, B.M., LIU, X.B., YANG, J.J., WANG, F., CONG, X.F., and CHEN, X. (2011). Identification of MicroRNAs involved in hypoxia- and serum deprivation-induced apoptosis in mesenchymal stem cells. Int. J. Biol. Sci. 7, 762-768.
42. OLIVE, V., JIANG, I., and HE, L. (2010). mir-17-92, a cluster of miRNAs in the midst of the cancer network. Int. J. Biochem. Cell. Biol. 42, 1348-1354.
43. PATEL, V., WILLIAMS, D., HAJARNIS, S., HUNTER, R., PONTOGLIO, M., SOMLO, S., and IGARASHI, P. (2013). miR-17 92 miRNA cluster promotes kidney cyst growth in polycystic kidney disease. Proc. Natl. Acad. Sci. U. S. A. 110, 10765-10770.
44. PETROCCA, F., VISONE, R., ONELLI, M.R., SHAH, M.H., NICOLOSO, M.S., DE MARTINO, I., ILIOPOULOS, D., PILOZZI, E., LIU, C.G., NEGRINI, M., et al. (2008). E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer. Cancer Cell. 13, 272-286.
45. PRACHASILCHAI, W., SONODA, H., YOKOTA-IKEDA, N., OSHIKAWA, S., AIKAWA, C., UCHIDA, K., ITO, K., KUDO, T., IMAIZUMI, K., and IKEDA, M. (2008). A protective role of unfolded protein response in mouse ischemic acute kidney injury. Eur. J. Pharmacol. 592, 138-145.
46. REGNER, K.R., NOZU, K., LANIER, S.M., BLUMER, J.B., AVNER, E.D., SWEENEY, W.E., JR., and PARK, F. (2011). Loss of activator of G-protein signaling 3 impairs renal tubular regeneration following acute kidney injury in rodents. FASEB J. 25, 1844-1855.
47. ROY, S., KHANNA, S., HUSSAIN, S.R., BISWAS, S., AZAD, A., RINK, C., GNYAWALI, S., SHILO, S., NUOVO, G.J., and SEN, C.K. (2009). MicroRNA expression in response to murine myocardial infarction: MiR-21 regulates fibroblast metalloprotease- 2 via phosphatase and tensin homologue. Cardiovasc. Res. 82, 21-29.
48. SAIKUMAR, J., HOFFMANN, D., KIM, T.M., GONZALEZ, V.R., ZHANG, Q., GOERING, P.L., BROWN, R.P., BIJOL, V., PARK, P.J., WAIKAR, S.S., and VAIDYA, V.S. (2012). Expression, circulation, and excretion profile of microRNA-21, -155, and -18a following acute kidney injury. Toxicol. Sci. 129, 256-267.
49. SCHMEIER, S., MACPHERSON, C.R., ESSACK, M., KAUR, M., SCHAEFER, U., SUZUKI, H., HAYASHIZAKI, Y., and BAJIC, V.B. (2009). Deciphering the transcriptional circuitry of microRNA genes expressed during human monocytic differentiation. BMC Genomics 10, 595.
50. SCHMIDT-OTT, K.M., MORI, K., KALANDADZE, A., LI, J.Y., PARAGAS, N., NICHOLAS, T., DEVARAJAN, P., and BARASCH, J. (2006). Neutrophil gelatinase-associated lipocalinmediated iron traffic in kidney epithelia. Curr. Opin. Nephrol. Hypertens. 15, 442-449.
51. SHEN, J., YANG, X., XIE, B., CHEN, Y., SWAIM, M., HACKETT, S.F., and CAMPOCHIARO, P.A. (2008). MicroRNAs regulate ocular neovascularization. Mol. Ther. 16, 1208-1216.
52. TAGUCHI, A., YANAGISAWA, K., TANAKA, M., CAO, K., MATSUYAMA, Y., GOTO, H., and TAKAHASHI, T. (2008). Identification of hypoxia-inducible factor-1 alpha as a novel target for miR-17-92 microRNA cluster. Cancer Res. 68, 5540-5545.
53. THUM, T. (2012). MicroRNA therapeutics in cardiovascular medicine. EMBO Mol. Med. 4, 3-14.
54. VENTURA, A., YOUNG, A.G., WINSLOW, M.M., LINTAULT, L., MEISSNER, A., ERKELAND, S.J., NEWMAN, J., BRONSON, R.T., CROWLEY, D., STONE, J.R., et al. (2008). Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell 132, 875-886.
55. VENTURINI, L., BATTMER, K., CASTOLDI, M., SCHULTHEIS, B., HOCHHAUS, A., MUCKENTHALER, M.U., GANSER, A., EDER, M., and SCHERR, M. (2007). Expression of the miR-17- 92 polycistron in chronic myeloid leukemia (CML) CD34 + cells. Blood 109, 4399-4405.
56. WAXMAN, K.S., and HOLMES, G. (2012). Renal management in the critically ill patient. Surg. Clin. North Am. 92, 1503-1518.
57. WEI, Q., BHATT, K., HE, H.Z., MI, Q.S., HAASE, V.H., and DONG, Z. (2010). Targeted deletion of Dicer from proximal tubules protects against renal ischemia-reperfusion injury. J. Am. Soc. Nephrol. 21, 756-761.
58. XIAO, C., and RAJEWSKY, K. (2009). MicroRNA control in the immune system: Basic principles. Cell 136, 26-36.
59. XIAO, C., SRINIVASAN, L., CALADO, D.P., PATTERSON, H.C., ZHANG, B., WANG, J., HENDERSON, J.M., KUTOK, J.L., and RAJEWSKY, K. (2008). Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes. Nat. Immunol. 9, 405-414.
60. XU, X., KRIEGEL, A.J., LIU, Y., USA, K., MLADINOV, D., LIU, H., FANG, Y., DING, X., and LIANG, M. (2012). Delayed is-chemic preconditioning contributes to renal protection by upregulation of miR-21. Kidney Int. 82, 1167-1175.
61. YAN, H.L., XUE, G., MEI, Q., WANG, Y.Z., DING, F.X., LIU, M.F., LU, M.H., TANG, Y., YU, H.Y., and SUN, S.H. (2009). Repression of the miR-17-92 cluster by p53 has an important function in hypoxia-induced apoptosis. EMBO J. 28, 2719-2732.
62. YIN, C., WANG, X., and KUKREJA, R. C. (2008). Endogenous microRNAs induced by heat-shock reduce myocardial infarction following ischemia-reperfusion in mice. FEBS Lett. 582, 4137-4142.
63. ZHANG, L., HUANG, H., CHENG, J., LIU, J., ZHAO, H., VIZCAYCHIPI, M.P., and MA, D. (2011). Pre-treatment with isoflurane ameliorates renal ischemic-reperfusion injury in mice. Life Sci. 88, 1102-1107.
64. ZHANG, X., AZHAR, G., and WEI, J.Y. (2012). The expression of microRNA and microRNA clusters in the aging heart. PLoS One 7, e34688.
65. ZHOU, M., CAI, J., TANG, Y., and ZHAO, Q. (2013). MiR-17-92 cluster is a novel regulatory gene of cardiac ischemic/reperfusion injury. Med. Hypotheses 81, 108-110.